Finance

Lists
BIS:BKK
Bioscience Animal Health PCL
฿2,54
+1,60%
(+0,040) 1D
9 Okt., 16:40:00 GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for BIS...
Open
฿2,56
High
฿2,56
Low
฿2,46
Mkt. cap
797,56 m
Avg. vol.
974,46 k
Volume
49,80 k
Dividend
10,63%
Quarterly dividend
฿0,07
Ex-dividend date
24 Aug. 2026
P/E ratio
22,38
52-wk high
฿3,40
52-wk low
฿1,70
EPS
฿0,11
Shares outstanding
314,00 m
No. of employees
151
Open
฿2,56
High
฿2,56
Low
฿2,46
Mkt. cap
797,56 m
Avg. vol.
974,46 k
Volume
49,80 k
Dividend
10,63%
Quarterly dividend
฿0,07
Ex-dividend date
24 Aug. 2026
P/E ratio
22,38
52-wk high
฿3,40
52-wk low
฿1,70
EPS
฿0,11
Shares outstanding
314,00 m
No. of employees
151
News stories
From web sources and news partners
About Bioscience Animal Health PCL
CEO-
Employees151
Founded20 Feb. 2004
Headquarters-
SectorHealth care provider
Previous reportsAll values in THB
Loading Previous Earnings...
Revenue
Net income
All values in THB
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
534,91 m
597,56 m
520,68 m
571,90 m
Cost of goods sold
468,18 m
498,18 m
450,07 m
495,14 m
Cost of revenue
468,18 m
498,18 m
450,07 m
495,14 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,47 m
118,59 m
61,31 m
62,51 m
Operating expense
52,34 m
108,24 m
49,35 m
55,90 m
Total operating expenses
520,52 m
606,43 m
499,42 m
551,04 m
Operating income
14,39 m
-8,86 m
21,26 m
20,86 m
Other non operating income
-
-
-
-
EBT including unusual items
14,14 m
-8,89 m
21,21 m
20,80 m
EBT excluding unusual items
14,14 m
-8,89 m
21,21 m
20,80 m
Income tax expense
2,91 m
-1,37 m
4,26 m
3,38 m
Effective tax rate
20,57%
15,38%
20,09%
16,26%
Other operating expenses
-9,14 m
-10,35 m
-11,96 m
-6,62 m
Net income
9,63 m
-8,30 m
15,83 m
16,78 m
Net profit margin
1,80%
-1,39%
3,04%
2,93%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-245,00 k
-30,00 k
-54,00 k
-66,00 k
Net interest expenses
-245,00 k
-30,00 k
-54,00 k
-66,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
19,47 m
-4,92 m
25,87 m
24,63 m
Gain or loss from assets sale
-
-4,00 k
-416,00 k
-2,00 k
AI content may include mistakes. Learn more
Google-programme